MicroRNA-375 inhibits colorectal cancer growth by targeting PIK3CA

被引:99
|
作者
Wang, Yihui [1 ]
Tang, Qingchao [2 ]
Li, Mingqi [1 ]
Jiang, Shixiong [1 ]
Wang, Xishan [2 ]
机构
[1] Harbin Med Univ, Affiliated Hosp 3, Dept Colorectal Surg, Harbin 150081, Peoples R China
[2] Harbin Med Univ, Affiliated Hosp 2, Ctr Canc, Harbin 150086, Peoples R China
关键词
miR-375; Colorectal cancer; PIK3CA; PI3K; Akt; PI3K-AKT PATHWAY; DOWN-REGULATION; GASTRIC-CANCER; MIR-375; PROTEIN; CELLS; PROGRESSION; EXPRESSION; NEOPLASIA; CARCINOMA;
D O I
10.1016/j.bbrc.2014.01.028
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Colorectal cancer (CRC) is the second most common cause of death from cancer. MicroRNAs (miRNAs) represent a class of small non-coding RNAs that control gene expression by triggering RNA degradation or interfering with translation. Aberrant miRNA expression is involved in human disease including cancer. Herein, we showed that miR-375 was frequently down-regulated in human colorectal cancer cell lines and tissues when compared to normal human colon tissues. PIK3CA was identified as a potential miR-375 target by bioinformatics. Overexpression of miR-375 in SW480 and HCT15 cells reduced PIIGCA protein expression. Subsequently, using reporter constructs, we showed that the PIK3CA untranslated region (3'-UTR) carries the directly binding site of miR-375. Additionally, miR-375 suppressed CRC cell proliferation and colony formation and led to cell cycle arrest. Furthermore, miR-375 overexpression resulted in inhibition of phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathway. SiRNA-mediated silencing of PIK3CA blocked the inhibitory effect of miR-375 on CRC cell growth. Lastly, we found overexpressed miR-375 effectively repressed tumor growth in xenograft animal experiments. Taken together, we propose that overexpression of miR-375 may provide a selective growth inhibition for CRC cells by targeting PI3K/Akt signaling pathway. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:199 / 204
页数:6
相关论文
共 50 条
  • [31] Clinicopathologic and molecular associations of PIK3CA and PTEN mutation in colorectal cancer
    Day, Fiona Lee
    Desai, Jayesh
    Jorissen, Robert N.
    Gibbs, Peter
    Mouradov, Dmitri
    Li, Shan
    Sieber, Oliver
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [32] Prognostic and Predictive Value of PIK3CA Mutations in Metastatic Colorectal Cancer
    Tan, Elaine S.
    Fan, Wenyi
    Knepper, Todd C.
    Schell, Michael J.
    Sahin, Ibrahim H.
    Fleming, Jason B.
    Xie, Hao
    TARGETED ONCOLOGY, 2022, 17 (04) : 483 - 492
  • [33] The prognostic role of KRAS, BRAF, PIK3CA and PTEN in colorectal cancer
    V Eklöf
    M L Wikberg
    S Edin
    A M Dahlin
    B-A Jonsson
    Å Öberg
    J Rutegård
    R Palmqvist
    British Journal of Cancer, 2013, 108 : 2153 - 2163
  • [34] Testing for PIK3CA and BRAF Mutations in Colorectal Cancer with Microsatellite Instability
    Murtaza, S.
    Fadhil, W. M.
    Hassall, J.
    Ebili, H. O.
    Ilyas, M.
    JOURNAL OF PATHOLOGY, 2018, 246 : S32 - S32
  • [35] Colorectal cancer: cetuximab, KRAS, BRAF, PIK3CA mutations and beyond
    Katsios, Christos
    Ziogas, Dimosthenis E.
    Roukos, Dimitrios H.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2010, 4 (05) : 525 - 529
  • [36] Mutation of the PIK3CA gene as a prognostic factor in patients with colorectal cancer
    Stec, Rafal
    Semeniuk-Wojtas, Aleksandra
    Charkiewicz, Radoslaw
    Bodnar, Lubomir
    Korniluk, Jan
    Smoter, Marta
    Chyczewski, Lech
    Niklinski, Jacek
    Szczylik, Cezary
    ONCOLOGY LETTERS, 2015, 10 (03) : 1423 - 1429
  • [37] PIK3CA mutation is predictive of poor survival in patients with colorectal cancer
    Kato, Shunsuke
    Iida, Satoru
    Higuchi, Tetsuro
    Ishikawa, Toshiaki
    Takagi, Yoko
    Yasuno, Masamichi
    Enomoto, Masayuki
    Uetake, Hiroyuki
    Sugihara, Kenichi
    INTERNATIONAL JOURNAL OF CANCER, 2007, 121 (08) : 1771 - 1778
  • [38] Prognostic and Predictive Value of PIK3CA Mutations in Metastatic Colorectal Cancer
    Elaine S. Tan
    Wenyi Fan
    Todd C. Knepper
    Michael J. Schell
    Ibrahim H. Sahin
    Jason B. Fleming
    Hao Xie
    Targeted Oncology, 2022, 17 : 483 - 492
  • [39] microRNA-375 inhibits the malignant behaviors of hepatic carcinoma cells by targeting NCAPG2
    Dai, Hai-Tao
    Wang, Shu-Tong
    Chen, Bin
    Tang, Ke-Yu
    Li, Nan
    Wen, Chun-Yong
    Wan, Yuan
    Zhang, Gui-Yuan
    Huang, Yong-Hui
    Geng, Zhi-Jun
    NEOPLASMA, 2022, 69 (01) : 16 - 27
  • [40] KRAS, BRAF and PIK3CA mutations in human colorectal cancer: Relationship with metastatic colorectal cancer
    Li, Hong-Tao
    Lu, Yuan-Yuan
    An, Yan-Xin
    Wang, Xin
    Zhao, Qing-Chuan
    ONCOLOGY REPORTS, 2011, 25 (06) : 1691 - 1697